Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial
Autor: | Bennett, Chijioke, Hoosain, Zaheer, Koen, Anthonet, Lalloo, Umesh, Louw, Cheryl, Maluleke, Vongane, Patel, Faeezah, Benade, Gabriella, Venter, Esme Louise, Galbiati, Shirley, Shinde, Vivek, Madhi, Shabir A. |
---|---|
Zdroj: | In Journal of Infection December 2024 89(6) |
Databáze: | ScienceDirect |
Externí odkaz: |